Schedule 13D ownership disclosure

RESPONSE BIOMEDICAL CORP

Security class unavailable · CUSIP: 76123L303

Event date: 2016-11-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-16-001737
Form type
SC 13D/A
Filer
ORBIMED ADVISORS LLC
CIK
CIK 1055951
Filed
Dec 01, 2016
Reporting period
Nov 29, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub